Evidence map›Paper›PMID 35589964›Full record

SynthesisInternational journal of obesity (2005)2022

ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19.

Julia S El-Sayed Moustafa, Anne U Jackson, Sarah M Brotman, Li Guan, Sergio Villicaña, Amy L Roberts, Antonino Zito, Lori Bonnycastle, Michael R Erdos, Narisu Narisu and 26 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in International journal of obesity (2005), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Genetic regulation of fatty acid content in adipose tissue.American journal of human genetics · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Genetic effects on the skin methylome in healthy older twins.American journal of human genetics · 2024
    Article
  10. The Functions of SARS-CoV-2 Receptors in Diabetes-Related Severe COVID-19.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors at 7 institutions in 4 countries.

Julia S El-Sayed Moustafa *Department of Twin Research and Genetic Epidemiology, King's College London, London, UK. julia.el-sayed_moustafa@kcl.ac.uk.ORCID 0000-0001-6963-6654
Anne U Jackson *Department of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-9672-2547
Sarah M Brotman *Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.ORCID 0000-0002-7566-8895
Li Guan *Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Sergio VillicañaDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.ORCID 0000-0002-2455-7095
Amy L RobertsDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Antonino ZitoDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.ORCID 0000-0003-1931-984X
Lori BonnycastleNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Michael R ErdosNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Narisu NarisuNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Heather M StringhamDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-2991-6392
Ryan WelchDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Tingfen YanNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Timo LakkaInstitute of Biomedicine/Physiology, University of Eastern Finland, Kuopio, Finland.ORCID 0000-0002-9199-2871
Stephen ParkerDepartment of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Jaakko TuomilehtoUniversity of Helsinki and Department of Medicine, Helsinki University Hospital, Helsinki, Finland.
Jeffrey SeowDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
Carl GrahamDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
Isabella HuettnerDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
Sam AcorsDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
Neophytos KouphouDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
Samuel WadgeDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Emma L DuncanDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Claire J StevesDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Katie J DooresDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
Michael H MalimDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.ORCID 0000-0002-7699-2064
Francis S CollinsNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Päivi PajukantaDepartment of Human Genetics and Institute for Precision Health, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Michael BoehnkeDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-6442-7754
Heikki A KoistinenUniversity of Helsinki and Department of Medicine, Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0001-7870-070X
Markku LaaksoDepartment of Medicine, University of Eastern Finland, Kuopio, Finland.ORCID 0000-0002-3394-7749
Mario FalchiDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.ORCID 0000-0002-5646-1004
Jordana T BellDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.ORCID 0000-0002-3858-5986
Laura J ScottDepartment of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Karen L MohlkeDepartment of Genetics, University of North Carolina, Chapel Hill, NC, USA.ORCID 0000-0001-6721-153X
Kerrin S SmallDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK. kerrin.small@kcl.ac.uk.ORCID 0000-0003-4566-0005
King's College London · GBUniversity of Michigan · USNational Institutes of Health · USUniversity of Eastern Finland · FIUniversity of Helsinki · FIUniversity of North Carolina at Chapel Hill · USHarvard University · US

Funding

Systems genomics of metabolic syndrome traitsP01HL028481 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DAVIS, RICHARD C · 1985 to 2019
$50.2M
Genetic analysis of type II diabetes in Finnish populationZIAHG000024 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ERDOS, MICHAEL · 2009 to 2025
$38.2M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Identifying Genes for Type 2 Diabetes: FUSIONU01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2009 to 2021
$11.6M
Targeted Genetic Analysis of T2D and Quantitative TraitsR01DK072193 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN L. MOHLKE · 2005 to 2026
$11.3M
Genetic epidemiology of rare and regulatory variants for metabolic traitsR01DK093757 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN L. MOHLKE · 2011 to 2026
$8.2M
Identifying Genes for Type 2 Diabetes:FUSIONR01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2003 to 2025
$6.7M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
Intramural NIH HHS ZIA HG000024Medical Research Council MR/L01999X/1Medical Research Council MR/M004422/1Medical Research Council MR/R023131/1NHLBI NIH HHS P01 HL028481NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK062370NIDDK NIH HHS R01 DK072193NIDDK NIH HHS R01 DK093757NIDDK NIH HHS U01 DK062370NIGMS NIH HHS T32 GM007092Wellcome Trust 221574
6 · The paper itself

Abstract

backgroundCOVID-19 severity varies widely. Although some demographic and cardio-metabolic factors, including age and obesity, are associated with increasing risk of severe illness, the underlying mechanism(s) are uncertain. SUBJECTS/

methodsIn a meta-analysis of three independent studies of 1471 participants in total, we investigated phenotypic and genetic factors associated with subcutaneous adipose tissue expression of Angiotensin I Converting Enzyme 2 (ACE2), measured by RNA-Seq, which acts as a receptor for SARS-CoV-2 cellular entry.

resultsLower adipose tissue ACE2 expression was associated with multiple adverse cardio-metabolic health indices, including type 2 diabetes (T2D) (P = 9.14 × 10

conclusionsOur results demonstrate that individuals with cardio-metabolic features known to increase risk of severe COVID-19 have lower background ACE2 levels in this highly relevant tissue. Reduced adipose tissue ACE2 expression may contribute to the pathophysiology of cardio-metabolic diseases, as well as the associated increased risk of severe COVID-19.

Indexed as

Adipose TissueAngiotensin-Converting Enzyme 2COVID-19Cardiometabolic Risk FactorsDiabetes Mellitus, Type 2Endothelial CellsHumansObesitySARS-CoV-2Angiotensin-Converting Enzyme 2

Identifiers

PMID35589964
PMCPMC9119844
OpenAlexW4280625549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.